875 related articles for article (PubMed ID: 25777539)
1. Somatostatin prevents lipopolysaccharide-induced neurodegeneration in the rat substantia nigra by inhibiting the activation of microglia.
Bai L; Zhang X; Li X; Liu N; Lou F; Ma H; Luo X; Ren Y
Mol Med Rep; 2015 Jul; 12(1):1002-8. PubMed ID: 25777539
[TBL] [Abstract][Full Text] [Related]
2. Fluoxetine prevents LPS-induced degeneration of nigral dopaminergic neurons by inhibiting microglia-mediated oxidative stress.
Chung ES; Chung YC; Bok E; Baik HH; Park ES; Park JY; Yoon SH; Jin BK
Brain Res; 2010 Dec; 1363():143-50. PubMed ID: 20858471
[TBL] [Abstract][Full Text] [Related]
3. Modulation of M1/M2 polarization by capsaicin contributes to the survival of dopaminergic neurons in the lipopolysaccharide-lesioned substantia nigra in vivo.
Bok E; Chung YC; Kim KS; Baik HH; Shin WH; Jin BK
Exp Mol Med; 2018 Jul; 50(7):1-14. PubMed ID: 29968707
[TBL] [Abstract][Full Text] [Related]
4. Curcumin protects dopaminergic neurons against inflammation-mediated damage and improves motor dysfunction induced by single intranigral lipopolysaccharide injection.
Sharma N; Sharma S; Nehru B
Inflammopharmacology; 2017 Jun; 25(3):351-368. PubMed ID: 28409389
[TBL] [Abstract][Full Text] [Related]
5. Galangin Reduces the Loss of Dopaminergic Neurons in an LPS-Evoked Model of Parkinson's Disease in Rats.
Chen G; Liu J; Jiang L; Ran X; He D; Li Y; Huang B; Wang W; Fu S
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29267220
[TBL] [Abstract][Full Text] [Related]
6. Apocyanin, a Microglial NADPH Oxidase Inhibitor Prevents Dopaminergic Neuronal Degeneration in Lipopolysaccharide-Induced Parkinson's Disease Model.
Sharma N; Nehru B
Mol Neurobiol; 2016 Jul; 53(5):3326-3337. PubMed ID: 26081143
[TBL] [Abstract][Full Text] [Related]
7. Thrombin-induced microglial activation produces degeneration of nigral dopaminergic neurons in vivo.
Choi SH; Joe EH; Kim SU; Jin BK
J Neurosci; 2003 Jul; 23(13):5877-86. PubMed ID: 12843292
[TBL] [Abstract][Full Text] [Related]
8. Polydatin Prevents Lipopolysaccharide (LPS)-Induced Parkinson's Disease via Regulation of the AKT/GSK3β-Nrf2/NF-κB Signaling Axis.
Huang B; Liu J; Meng T; Li Y; He D; Ran X; Chen G; Guo W; Kan X; Fu S; Wang W; Liu D
Front Immunol; 2018; 9():2527. PubMed ID: 30455692
[TBL] [Abstract][Full Text] [Related]
9. Progressive loss of nigrostriatal dopaminergic neurons induced by inflammatory responses to fipronil.
Park JH; Park YS; Koh HC
Toxicol Lett; 2016 Sep; 258():36-45. PubMed ID: 27313094
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoids prevent lipopolysaccharide-induced neurodegeneration in the rat substantia nigra in vivo through inhibition of microglial activation and NADPH oxidase.
Chung ES; Bok E; Chung YC; Baik HH; Jin BK
Brain Res; 2012 Apr; 1451():110-6. PubMed ID: 22436849
[TBL] [Abstract][Full Text] [Related]
11. Potential repositioning of exemestane as a neuroprotective agent for Parkinson's disease.
Son HJ; Han SH; Lee JA; Shin EJ; Hwang O
Free Radic Res; 2017 Jun; 51(6):633-645. PubMed ID: 28770670
[TBL] [Abstract][Full Text] [Related]
12. Biochanin A Protects Against Lipopolysaccharide-Induced Damage of Dopaminergic Neurons Both In Vivo and In Vitro via Inhibition of Microglial Activation.
Wang J; Wu WY; Huang H; Li WZ; Chen HQ; Yin YY
Neurotox Res; 2016 Oct; 30(3):486-98. PubMed ID: 27417698
[TBL] [Abstract][Full Text] [Related]
13. GPER activation is effective in protecting against inflammation-induced nigral dopaminergic loss and motor function impairment.
Mendes-Oliveira J; Lopes Campos F; Videira RA; Baltazar G
Brain Behav Immun; 2017 Aug; 64():296-307. PubMed ID: 28450223
[TBL] [Abstract][Full Text] [Related]
14. Peiminine Protects Dopaminergic Neurons from Inflammation-Induced Cell Death by Inhibiting the ERK1/2 and NF-κB Signalling Pathways.
Chen G; Liu J; Jiang L; Ran X; He D; Li Y; Huang B; Wang W; Liu D; Fu S
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29534526
[TBL] [Abstract][Full Text] [Related]
15. 5-Chloroacetyl-2-amino-1,3-selenazoles attenuate microglial inflammatory responses through NF-kappaB inhibition.
Nam KN; Koketsu M; Lee EH
Eur J Pharmacol; 2008 Jul; 589(1-3):53-7. PubMed ID: 18538761
[TBL] [Abstract][Full Text] [Related]
16. Paroxetine prevents loss of nigrostriatal dopaminergic neurons by inhibiting brain inflammation and oxidative stress in an experimental model of Parkinson's disease.
Chung YC; Kim SR; Jin BK
J Immunol; 2010 Jul; 185(2):1230-7. PubMed ID: 20566832
[TBL] [Abstract][Full Text] [Related]
17. DL‑3‑n‑butylphthalide reduces microglial activation in lipopolysaccharide‑induced Parkinson's disease model mice.
Chen Y; Jiang M; Li L; Ye M; Yu M; Zhang L; Ge B; Xu W; Wei D
Mol Med Rep; 2018 Mar; 17(3):3884-3890. PubMed ID: 29286148
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of prothrombin kringle-2-induced inflammation by minocycline protects dopaminergic neurons in the substantia nigra in vivo.
Nam JH; Leem E; Jeon MT; Kim YJ; Jung UJ; Choi MS; Maeng S; Jin BK; Kim SR
Neuroreport; 2014 May; 25(7):489-95. PubMed ID: 24488033
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoid receptor is involved in the neuroprotective effect of ginsenoside Rg1 against inflammation-induced dopaminergic neuronal degeneration in substantia nigra.
Sun XC; Ren XF; Chen L; Gao XQ; Xie JX; Chen WF
J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt A):94-103. PubMed ID: 26455404
[TBL] [Abstract][Full Text] [Related]
20. Silibinin attenuates MPP⁺-induced neurotoxicity in the substantia nigra in vivo.
Jung UJ; Jeon MT; Choi MS; Kim SR
J Med Food; 2014 May; 17(5):599-605. PubMed ID: 24660866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
